Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Amir, Tavakkol"'
Autor:
Aditya K. Gupta, Amir Tavakkol, Steven Kempers, David M. Pariser, Kjell Rensfeldt, Maria S. Surprenant
Publikováno v:
Journal of the American Academy of Dermatology. 85:95-104
Onychomycosis is a recalcitrant fungal nail infection. Topical antifungal agents may be preferred over systemic agents due to lack of systemic adverse effects.To investigate the efficacy and safety of topical terbinafine 10% solution (MOB-015) for th
Autor:
Joyce M.C. Teng, Christopher G. Bunick, Scott Guenthner, Dedee F. Murrell, Kalyani Marathe, Steven Kempers, Kimmie Eads, Alan M. Mendelsohn, Jessica Raiz, Amir Tavakkol, Leslie Castelo-Soccio
Publikováno v:
Journal of the American Academy of Dermatology. 87(6)
Autor:
PR Newswire
Publikováno v:
PR Newswire US. 10/30/2017.
Autor:
Viamet Pharmaceuticals, Inc.
Publikováno v:
Business Wire (English). 07/22/2014.
Publikováno v:
Mycoses. 57:389-393
Luliconazole is a novel, broad-spectrum, imidazole antifungal under development in the USA as a treatment for dermatophytic skin and nail infections. In vitro, luliconazole is one of the most potent antifungal agents against filamentous fungi includi
Autor:
Karen Person, Stephen Brand, Paul Nyirjesy, Amir Tavakkol, Jack D. Sobel, Robert J. Schotzinger, Thorsten P. Degenhardt
Publikováno v:
American Journal of Obstetrics and Gynecology. 218:624.e1-624.e9
Background Lanosterol demethylase is an enzyme that is essential for fungal growth and catalyzes an early step in the biosynthetic pathway of ergosterol, which is a sterol that is required for fungal cell membrane formation and integrity. Lanosterol
Publikováno v:
Journal of the American Podiatric Medical Association. 96:465-473
This study was conducted to investigate the efficacy of oral terbinafine with and without aggressive debridement for the treatment of toenail onychomycosis. Onychomycosis patients aged 18 to 75 years received 12 weeks of terbinafine, 250 mg/day, alon
Publikováno v:
The American Journal of Geriatric Pharmacotherapy. 4:1-13
Objectives: The primary objective of this subanalysis was to examine the safety, tolerability, and efficacy of terbinafine in the treatment of toenail onychomycosis in the patients aged ≥65 years in the Improving Results in Onychomycosis Concomitan
Publikováno v:
Journal of the American Podiatric Medical Association. 95:421-424
Publikováno v:
Antimicrobial agents and chemotherapy. 58(6)
The in vitro activities of luliconazole, amorolfine, ciclopirox, and terbinafine were determined against 320 dermatophyte isolates from large toenails of onychomycosis patients enrolled into an ongoing phase 2b/3 clinical study. The geometric mean MI